199 related articles for article (PubMed ID: 7548800)
1. Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosis.
Chiang HT; Cheng JS; Lin M; Tseng WS; Chang JM; Lai KH
J Gastroenterol Hepatol; 1995; 10(3):256-60. PubMed ID: 7548800
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
[TBL] [Abstract][Full Text] [Related]
3. The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis.
Kong CW; Lay CS; Tsai YT; Yeh CL; Lai KH; Lee SD; Lo KJ; Chiang BN
Hepatology; 1986; 6(3):423-6. PubMed ID: 3710430
[TBL] [Abstract][Full Text] [Related]
4. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
[TBL] [Abstract][Full Text] [Related]
5. Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis.
Tripathi D; Therapondos G; Lui HF; Johnston N; Webb DJ; Hayes PC
Am J Gastroenterol; 2004 Feb; 99(2):390-4. PubMed ID: 15046234
[TBL] [Abstract][Full Text] [Related]
6. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
Ottesen LH; Flyvbjerg A; Møller S; Bendtsen F
Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
[TBL] [Abstract][Full Text] [Related]
7. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis.
Lin HC; Tsai YT; Lee FY; Chang TT; Wang SS; Lay CS; Lee SD; Lo KJ
J Hepatol; 1989 Nov; 9(3):326-30. PubMed ID: 2607121
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis].
Jeong PH; Baik SK; Choi YJ; Park DH; Kim MY; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Kim ND
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):264-70. PubMed ID: 12499783
[TBL] [Abstract][Full Text] [Related]
9. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension.
Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T
Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974
[TBL] [Abstract][Full Text] [Related]
10. A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP).
Gifford FJ; Dunne PDJ; Weir G; Ireland H; Graham C; Tuck S; Hayes PC; Fallowfield JA
Trials; 2020 Mar; 21(1):260. PubMed ID: 32164767
[TBL] [Abstract][Full Text] [Related]
11. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
Castaño G; Viudez P; Riccitelli M; Sookoian S
Ann Hepatol; 2003; 2(1):36-40. PubMed ID: 15094704
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Doppler ultrasonography and the hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis.
Choi YJ; Baik SK; Park DH; Kim MY; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW
J Gastroenterol Hepatol; 2003 Apr; 18(4):424-9. PubMed ID: 12653891
[TBL] [Abstract][Full Text] [Related]
13. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
Agasti AK; Mahajan AU; Phadke AY; Nathani PJ; Sawant P
J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
[TBL] [Abstract][Full Text] [Related]
14. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
15. Lack of effects of isosorbide-5-mononitrate on hepatic hemodynamics in HBsAg-positive cirrhosis.
Tsai YT; Lee FY; Lin HC; Chang TT; Lay CS; Wang SS; Kong CW; Lee SD; Lo KJ
Hepatology; 1989 Sep; 10(3):283-7. PubMed ID: 2759546
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.
Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of nifedipine on hepatic venous pressure gradient in patients with portal hypertension.
Straumann A; Gyr K; Kiowski W; Bruendler H; Stalder GA
Hepatogastroenterology; 1986 Jun; 33(3):101-4. PubMed ID: 3744280
[TBL] [Abstract][Full Text] [Related]
20. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis.
Grose RD; Plevris JN; Redhead DN; Bouchier IA; Hayes PC
J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
